Osong Public Health Res Perspect.  2021 Oct;12(5):286-292. 10.24171/j.phrp.2021.0140.

Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children

Affiliations
  • 1Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • 2Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
  • 3Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
  • 4Department of Microbiology, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran
  • 5Department of Medical Microbiology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  • 6Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • 7Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected many people around the world. Children are considered an important target group for SARS-CoV-2, as well as other viral infections such as respiratory syncytial virus infection. Both SARS-CoV-2 and respiratory syncytial virus can affect the respiratory tract. Coinfection of SARS-CoV-2 and respiratory syncytial virus can pose significant challenges in terms of diagnosis and treatment in children. This review compares the symptoms, diagnostic methods, and treatment of COVID-19 and respiratory syncytial virus infection in children.

Keyword

Child; COVID-19; Respiratory syncytial viruses; SARS-CoV-2
Full Text Links
  • OPHRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr